News

Intuitive Machines Inc (LUNR) posts a 4x revenue increase to $206 million and secures a record $1.8 billion backlog, positioning for sustained expansion despite ongoing profitability challenges.

Figure Technology Solutions Inc (FIGR) delivered record Q2 2026 consumer loan marketplace volume of $4.3 billion, up 132% year-over-year, while expanding adjusted EBITDA margins to 55%.

Record subscription revenue and strategic advances offset near-term crypto market headwinds.

Blaize (NASDAQ:BZAI) lowered its full-year 2026 revenue outlook to $40 million to $43 million, from prior guidance of $130 million, citing delayed customer deployments, commercial opportunities that did not convert as expected, higher memory costs and a provision tied to an outstanding Starshine rec

Legence Corp (LGN) reports 111% revenue growth and boosts full-year outlook amid strong demand across data centers and manufacturing.

Revenue surged 56% year over year as lidar shipments accelerated.

Revenue jumped 48% to $481 million on record royalty growth.

JBP clients surged 38% year over year despite macro headwinds slowing overall growth.

BranchOut Food (NASDAQ:BOF) reported record quarterly net revenue of $4.45 million, while management said investments tied to customer acquisition, expedited shipping and high-cost raw materials weighed on gross margin during the period. Chief Financial Officer John Dalfonsi said the company’s stra

Applied Materials (NASDAQ:AMAT) reported record fiscal third-quarter 2026 results, with revenue, operating profit and non-GAAP earnings per share reaching new highs as demand for AI-related semiconductor manufacturing equipment continued to strengthen. President and CEO Gary Dickerson said the comp

Strategic partnerships now fuel 30% of North American rides as autonomous vehicle operations expand.

Record revenue and backlog surge as defense demand accelerates.

All eyes are on HIVE Digital Technologies (Nasdaq: HIVE) this week as the Bitcoin miner prepares to open its books. The company will release its fiscal first-quarter 2027 results on Friday, Aug. 14, after the market closes, followed by an earnings conference call on Monday, Aug. 17, at ...

Moby summary of Creative Realities, Inc.'s Q2 2026 earnings call

Moby summary of Eagle Point Income Company Inc.'s Q2 2026 earnings call

Moby summary of Bragg Gaming Group Inc.'s Q2 2026 earnings call

Moby summary of SuperCom Ltd.'s Q2 2026 earnings call

Moby summary of Bullish's Q2 2026 earnings call

Moby summary of Birkenstock Holding plc's Q3 2026 earnings call

Moby summary of Beyond Air, Inc.'s Q1 2027 earnings call

Moby summary of Legence Corp. Class A Common stock's Q2 2026 earnings call

Applied Materials posted record third-quarter results and delivered a stronger-than-expected fourth-quarter forecast.

Brookfield (NYSE:BN) reported second-quarter distributable earnings before realizations of $1.4 billion, or $0.61 per share, up 15% per share from a year earlier, as growth in asset management and wealth solutions supported results. Total distributable earnings, including realizations, were $1.5 bi

Bullish (NYSE:BLSH) reported second-quarter results that showed revenue growth and positive adjusted EBITDA despite lower crypto prices and volatility, while executives emphasized tokenized securities and the pending Equiniti acquisition as central to the company’s longer-term strategy. Chief Execu

Sidus Space is set to report its Q2 earnings on Aug. 14. Here’s why investors are cautioned against owning SIDU shares ahead of the earnings event.

Moby summary of Intuitive Machines, Inc.'s Q2 2026 earnings call

Moby summary of American Shared Hospital Services's Q2 2026 earnings call

Moby summary of Aebi Schmidt Holding AG's Q2 2026 earnings call

Telesat (NASDAQ:TSAT) reported a second-quarter net loss of CAD 559 million as the satellite operator continued to invest in its Lightspeed low Earth orbit network, while its legacy geostationary-orbit business faced ongoing revenue pressure. Chief Financial Officer Donald Tremblay said the quarter

Valneva (NASDAQ:VALN) reported lower first-half revenue and wider losses for 2026, while maintaining its full-year sales outlook and emphasizing its cash position, restructuring measures and expectations for regulatory progress on its Lyme disease vaccine candidate with Pfizer. CEO Thomas Lingelbac